JP Patent

JP7441955B2 — インターロイキン２３受容体のペプチド阻害剤および炎症性疾患を治療するためのその使用

Assigned to ヤンセンバイオテツク，インコーポレーテツド · Expires 2024-03-01 · 2y expired

What this patent protects

Patent listed against null.

Drugs covered by this patent

Patent Metadata

Patent number: JP7441955B2
Jurisdiction: JP
Classification: —
Expires: 2024-03-01
Drug substance claim: No
Drug product claim: No
Assignee: ヤンセンバイオテツク，インコーポレーテツド
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.